Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
98,364,308
-
Total 13F shares
-
9,372,698
-
Share change
-
+4,318,899
-
Total reported value
-
$97,174,000
-
Price per share
-
$10.36
-
Number of holders
-
37
-
Value change
-
+$44,916,602
-
Number of buys
-
21
-
Number of sells
-
5
Institutional Holders of Oncology Institute, Inc. - Common (DFPH) as of Q3 2020
As of 30 Sep 2020,
Oncology Institute, Inc. - Common (DFPH) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,372,698 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, UBS OCONNOR LLC, DEUTSCHE BANK AG\, JPMORGAN CHASE & CO, HBK INVESTMENTS L P, WOLVERINE ASSET MANAGEMENT LLC, GLAZER CAPITAL, LLC, Kepos Capital LP, Man Group plc, and HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND.
This page lists
37
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.